STRO

NASDAQStock

Sutro Biopharma, Inc.

$23.38-1.07 (-4.40%)

52-Week Range

$5.25

$25.43

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.48

Volume

81.2K

Avg Volume

152.4K

Performance

+56.53%

+146.22%

+175.28%

YTD

+123.08%

+201.81%

-54.72%

-89.66%

Price Chart

ETF Exposure

STRO is held by 12 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VFLQ	Vanguard U.S. Liquidity Factor ETF	0.54%	6,117	$34K	$38.3M	0.13%
PQSG	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF	0.18%	1,391	$23K	$13.0M	—
IWC	iShares Micro-Cap ETF	0.04%	20,894	$513K	$1.27B	0.60%
PRFZ	Invesco RAFI US 1500 Small-Mid ETF	0.02%	17,138	$421K	$2.67B	0.34%
VXF	Vanguard Extended Market ETF	0.00%	81,540	$1.2M	$84.10B	0.05%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.00%	1	$24	$86.8M	1.19%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	11	$234	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	413	$8K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	2	$40	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	235,624	$3.5M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	1,239	$25K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	106	$2K	$1.29B	0.17%

About STRO ETF Exposure

Sutro Biopharma, Inc. (STRO) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $23.38. Investors can gain exposure to STRO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold STRO, sorted by portfolio weight.